Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NYSE
MRK

Market Cap: $317.06B

MI

Merck & Co., Inc.

MRK

NYSE (New York Stock Exchange)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin75.91%

EBITDA Margin28.63%

EBIT Margin19.32%

Pre-tax Margin17.73%

Net Profit Margin13.62%

Earnings Yield2.77%

Valuation Multiples

Price / Book7.03

Price / Sales4.91

Price / Earnings36.63

PEG-0.76

Forward PEG0.15

EV / Sales5.58

EV / EBITDA19.48

EV / Operating Cash Flow20.45

EV / Free Cash Flow25.92

Price / Free Cash Flow22.82

Price / Operating Cash Flow18.02

Cash Flow & Capital

Free Cash Flow / Share$5.71

Operating Cash Flow / Share$7.24

Free Cash Flow Yield4.38%

Capex / Revenue5.76%

Capex / Operating Cash Flow21.10%

Capex / Depreciation0.73

Stock Compensation / Revenue1.23%

Dividend Payout Ratio92.12%

Dividend Yield2.58%

Liquidity & Leverage

Current Ratio1.30

Quick Ratio1.06

Cash Ratio0.20

Debt / Assets0.38

Debt / Capital0.52

Debt / Equity1.07

Long-Term Debt / Capital0.50

Debt / Market Cap15.25%

Net Debt / EBITDA2.33

Solvency Ratio0.18

Financial Leverage2.80

Efficiency & Working Capital

Asset Turnover0.51

Fixed Asset Turnover2.58

Inventory Turnover2.44

Receivables Turnover5.37

Payables Turnover4.09

Days Sales Outstanding67.94

Days Inventory Outstanding149.65

Days Payables Outstanding89.23

Operating Cycle217.6

Cash Conversion Cycle128.37

Working Capital Turnover5.64

Returns & Quality

Return on Equity17.93%

Return on Assets6.94%

Return on Invested Capital13.34%

ROCE17.79%

Return on Tangible Assets10.98%

Operating Return on Assets13.63%

Income Quality2.00

Tax Burden0.77

Interest Burden0.92

Balance Sheet & Intrinsic Metrics

Enterprise Value$365.83B

Invested Capital$80.83B

Working Capital$8.07B

Tangible Asset Value$-1.4B

Net Current Asset Value$-47.74B

Graham Number$38.85

Graham Net-Net-$26.15

Book Value / Share$18.58

Tangible Book Value / Share-$0.56

Cash / Share$2.31

Financial Health Scores

Piotroski Score6

Altman Z-Score4.04

Revenue$65.59B

EBIT$12.67B

Market Cap$331.47B

Working Capital$8.07B

Retained Earnings$66.72B

Total Assets$128.69B

Total Liabilities$82.75B